Le Lézard
Classified in: Health, Science and technology
Subject: SVY

Biopharmaceutical Bioseparation Systems Market Report 2019 - Global Annual Market Analysis, Trends, and Forecasts 2016-2024


DUBLIN, May 23, 2019 /PRNewswire/ -- The "Biopharmaceutical Bioseparation Systems - Market Analysis, Trends, and Forecasts" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa, and Latin America. Annual estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.

This report analyzes the worldwide markets for Biopharmaceutical Bioseparation Systems in US$ Million by the following Product Segments:

The report profiles 55 companies including many key and niche players such as

Key Topics Covered: 

1. OUTLOOK
Bioseparation Systems
Invaluable Tools in Biopharmaceutical Manufacturing
US Remains Market Leader; Developing Countries to Drive Market Growth
Chromatography Leads the Pack
Global Market for Gas Chromatography Systems
Competitive Landscape 


2. INDUSTRY OVERVIEW
A Peek into Biopharmaceutical Manufacturing
Downstream Processing of Biosynthetic Products
An Overview
Growing Biopharmaceutical Market Drives Demand for Bioseparation Systems
New Biologic License Application (BLA) Approvals-2017
New Biologic License Application (BLA) Approvals: 2016
New Biologic License Application (BLA) Approval: 2015
Biopharmaceutical Industry Transforms Downstream Processing
Growing Biological Drug Manufacturing Capacity to Drive Growth
Growing Market for Monoclonal Antibodies
A Key Review of Current Status and Future Prospects
Approved Monoclonal Antibodies: 2014-2017
An Insight into Bioseparation of mAbs
Growing Biosimilars Market
A Clear Advantage for Bioseparation Technologies
Patent Expiries of Major Biopharmaceutical Drugs in the US and Europe
US APPROVED BIOSIMILARS AS OF DECEMBER 2017
EUROPE APPROVED BIOSIMILARS AS OF DECEMBER 2017
R&D Funding Crucial for Biologics and Bioseparation Market
Huge Biopharmaceutical Pipeline
A Clear Indicator of Future Prospects

3. BIOSEPARATION TECHNOLOGIES KEY MARKET TRENDS
Increasing Need for Further Advances in Downstream Processing Techniques
Process Optimization and Cost Reduction
Key Goals of Innovations in Bioseparation
Continuous Bioseparation Gains Momentum
Process Intensification
Single-Use Systems Play a Key Role
Minimizing Centrifugation Steps
Integration of Down-Stream and Up-Stream
Developmental Efforts
Focus on Enhancing Capture Increases
Introduction of Diversified Resins on the Rise
Multicolumn System Lower Buffer and Resin Requirement
Single-Use Disposable Technologies Gain Attention
Select Commercial Disposable/Single-Use Technologies by Process Technique
Innovations in Single-use Systems
Increasing Biopharma Productivity and Efficiency via Continuous Manufacturing
Changing Paradigm of Primary Recovery in Bioseparation
Growing Use of Membrane Filtration in Biopharmaceutical Manufacturing
Chromatography
The Gold Standard Purification Technology
Continuous Chromatography- A Key Technology for the Biopharma Sector
Challenges to Separate Active Pharmaceutical Ingredients, Chromatography to the Rescue
Inherent Benefits of Membrane Chromatography to Drive its Use in Bioprocessing
SMBC
An Old Approach Gaining Significant Attention
Superior Efficiency Drives Use of Synthetic Ligands in Affinity Chromatography
A Comparison of Protein and Synthetic Ligands
Increasing Alternatives to Protein A Column based Capturing
Twin-Column SMB
An Emerging Alternative to Protein A Columns
Chiral Chromatography Increases in Popularity
Flexible and Selective Chromatography Improves Biopharmaceutical Efficiencies
Chromatography Efficiency and Selectivity
Mixed-Mode Chromatography
Multimode Chromatography
Mixed-Mode and Multimode Media Offer Cost Savings
Awareness of Mixed Mode and Multimode Media Operating Modes Critical
Magnetic Separation as an Alternative to Chromatography
A Review
Reversible Precipitation
A Novel Bioseparation Technology

4. PRODUCT OVERVIEW
Biological Products
An Overview
Classification of Biological Products by Application
Classification of Biological Products by Chemical Nature
Bioseparation
An Overview
Commonly Used Bioseparation Processes by Factors
Bioseparation
A Challenging, Complex, and Expensive Process
Stages of Biomolecule Recovery and Relevant Bioseparation Techniques Used
Classification of Bioseparation Techniques based on Resolution and Throughput
Bioseparation Costs as a Percentage of Processing by Biological Product
Key Bioseparation Techniques
Chromatography
Centrifugation
Membrane Separation
Filtration
Overview of Other Bioseparation Techniques
Adsorption
Extraction
Precipitation
Classification of Bioseparation Techniques based on Physical Form
Particle-Liquid Separation
Particle-Particle Separation
Solute-Solvent Separation
Solute-Solute Separation
Liquid-Liquid Separation
Particle-Solute Separation
RIPP in Bioseparation
The Conventional Scheme for Developing Processes

5. PRODUCT INTRODUCTIONS/APPROVALS
GE Healthcare Introduces MabSelect PrismA
Pall Introduces Flexible Single-use Chromatography System
MilliporeSigma Launches Eshmuno Affinity Chromatography Resins
PerkinElmer Introduces Clarus 590 and 690 GC Instruments
Sartorius Stedim Biotech Releases Sartobind Cassettes
Ellutia Chromatography Solutions Unveils 500 Series Range of Instruments
Kaneka Corporation Launches KANEKA KanCapA 3G
Pall Life Sciences Introduces Cadence BioSMB Process System
Thermo Fisher Exhibits SMART Digest Kit
Merck Launches Wide Range of Products for Separation and Analysis
Agilent Technologies Introduces New Line of AdvanceBio SEC Columns

6. RECENT INDUSTRY ACTIVITY
Waters Corp. Launches ACQUITY Arc Bio System
GE Healthcare Acquires Puridify
MilliporeSigma Inks MoU with Samsung BioLogics
Merck Acquires Natrix Separations
Repligen Merges with Spectrum Labs
Waters Enters into a Co-Marketing Agreement with Wyatt Technology
JLS Expands Amsphere A3 Production Capacity
YMC Buys Land in the Annex Kyoto Miwa Industrial Park
KNAUER and 3B Pharmaceuticals Delivers Purification Process for Camelid Antibodies
ATG Enters into a Service Agreement with LEWA-Nikkiso America
Repligen Buys Atoll
Pall Enters into a Supply Agreement with KANEKA
Merck Acquires Sigma-Aldrich
EMD Millipore Launches Sterilizing-Grade Millipore Express PHF Hydrophilic Filters
Anteo Diagnostics Inks South Korean Distribution Agreement with KomaBiotech
GE Healthcare and Sartorius Stedim Biotech Ink OEM Supply Agreement for Sartobind Technology
EMD Millipore Unveils Pellicon Tangential Flow Filtration System
ImmunoReagents and ProteoVec Launch PV-Pure Ig Antibody Purification Kits
Pall Acquires Tarpon's BioSMB Platform

7. FOCUS ON SELECT PLAYERS

8. GLOBAL MARKET PERSPECTIVE

Total Companies Profiled:

For more information about this report visit https://www.researchandmarkets.com/r/gfyn3n

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets


These press releases may also interest you

at 07:25
Owlstone Medical ("Owlstone"), the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, today announced it has secured funding from the Bill & Melinda Gates Foundation ("the Gates Foundation" or "the...

at 07:20
Onconic Therapeutics, a leading biotechnology company in Korea, today announced that the Ministry of Food and Drug Safety (MFDS) of Korea has approved JAQBO (zastaprazan citrate) for the treatment of erosive gastroesophageal reflux disease (GERD) in...

at 07:16
S&P Global today reported first quarter 2024 results. The Company's earnings release and supplemental materials are available at http://investor.spglobal.com/Quarterly-Earnings. Supplemental Information/Conference Call/Webcast Details: The...

at 07:16
Huawei is presenting its innovative Intelligent Distribution Solution (IDS) at the 26th World Energy Congress in Rotterdam. Developed in collaboration with ecosystem partners, the IDS aims to tackle the electric power industry's most pressing...

at 07:15
Draganfly Inc. ("Draganfly" or the "Company"), an award-winning, industry-leading drone solutions and systems developer is pleased to announce a strategic collaboration with ParaZero Technologies Ltd., a pioneer in drone safety systems aimed at...

at 07:10
Science Corporation ("Science"), a leader in brain-computer interface ("BCI") technology and the developer of the Science Eye, has acquired the IP and related assets for the PRIMA retinal implant, developed by Pixium Vision SA ("Pixium") of France, a...



News published on and distributed by: